Domperidone 30mg + Rabeprazole 20mg capsule is a combination gastrointestinal therapy formulated for the effective management of acid-related disorders associated with impaired gastric motility.
Rabeprazole works by suppressing gastric acid secretion at the proton pump level, while domperidone enhances upper gastrointestinal motility and accelerates gastric emptying, helping reduce symptoms such as acidity, heartburn, bloating, nausea, and regurgitation.
This capsule is commonly prescribed for gastroesophageal reflux disease (GERD), chronic gastritis, functional dyspepsia, acid peptic disorders, and reflux-associated nausea or vomiting.
With dual-action efficacy, strong prescription acceptance, and relevance in both short-term and long-term gastric care, this formulation supports consistent therapeutic demand and strengthens a comprehensive gastrointestinal product portfolio.